About this Journal Submit a Manuscript Table of Contents
ISRN Biomarkers
Volume 2013 (2013), Article ID 873953, 6 pages
http://dx.doi.org/10.1155/2013/873953
Review Article

Diagnostically Relevant Molecular Markers in Head and Neck Neoplasms

1Department of Oral Pathology and Microbiology, Mar Baselious Dental College and Hospital, Kothamangalam, Kerala, India
2Department of Oral Medicine and Radiology, Rajah Muthiah Dental College and Hospital, Annamalai University, Chidambaram, Tamil Nadu, India
3Department of Oral Pathology and Microbiology, Indiragandhi Dental College, Kothamangalam, Kerala, India

Received 15 March 2013; Accepted 16 May 2013

Academic Editors: R. Smith and Z. Wang

Copyright © 2013 Soma Susan Varghese et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. J. Pelkey, H. F. Frierson, and D. E. Bruns, “Molecular and immunologicaldetection of circulating tumor cells and micrometastases from solidtumors,” Clinical Chemistry, vol. 42, pp. 1369–1381, 1996.
  2. G. V. Raj, J. G. Moreno, and L. G. Gomella, “Utilization of polymerase chainreaction technology in the detection of solid tumors,” Cancer, vol. 82, pp. 1419–1442, 1998.
  3. M. L. Costa, R. Escaleira, A. Cataldo, F. Oliveira, and C. S. Mermelstein, “Desmin: molecular interactions and putative functions of the muscle intermediate filament protein,” Brazilian Journal of Medical and Biological Research, vol. 37, no. 12, pp. 1819–1830, 2004. View at Scopus
  4. D. M. Parham, B. Webber, H. Holt, W. K. Williams, and H. Maurer, “Immunohistochemical study of childhood rhabdomyosarcomas and related neoplasms: results of an Intergroup Rhabdomyosarcoma Study project,” Cancer, vol. 67, no. 12, pp. 3072–3080, 1991. View at Scopus
  5. A. K. Breuks and M. J. Trotter, “Expression of desmin and smooth muscle myosin heavy chain in dermato fibromatosis,” Archives of Pathology & Laboratory Medicine, vol. 126, p. 1179, 2002.
  6. A. L. Folpe, J. R. Goldblum, B. P. Rubin et al., “Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases,” American Journal of Surgical Pathology, vol. 29, no. 8, pp. 1025–1033, 2005. View at Scopus
  7. D. M. Parham, P. Dias, D. R. Kelly, J. C. Rutledge, and P. Houghton, “Desmin positivity in primitive neuroectodermal tumors of childhood,” American Journal of Surgical Pathology, vol. 16, no. 5, pp. 483–492, 1992. View at Scopus
  8. W. Ruan and M. Lai, “Actin, a reliable marker of internal control?” Clinica Chimica Acta, vol. 385, no. 1-2, pp. 1–5, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Tsukada, D. Tippens, and D. Gordon, “HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemial and biochemical characterization,” American Journal of Pathology, vol. 126, no. 1, pp. 51–60, 1987. View at Scopus
  10. E. A. Montgomery and J. M. Meis, “Nodular fescitis, its morphogenic spectrum and immunohistochemicl profile,” American Journal of Surgical Pathology, vol. 15, p. 942, 1991.
  11. I. O. Bello, K. Alanen, P. J. Slootweg, and T. Salo, “Alpha-smooth muscle actin within epithelial islands is predictive of ameloblastic carcinoma,” Oral Oncology, vol. 45, no. 9, pp. 760–765, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Rosai, P. Dias, D. M. Parham, D. N. Shapiro, and P. Houghton, “MyoD1 protein expression in alveolar soft part sarcoma as confirmatory evidence of its skeletal muscle nature,” American Journal of Surgical Pathology, vol. 15, no. 10, pp. 974–981, 1991. View at Scopus
  13. J. J. Brooks, “Immunohistochemistry of soft tissue tumors. Myoglobin as a tumor marker for rhabdomyosarcoma,” Cancer, vol. 50, no. 9, pp. 1757–1763, 1982. View at Scopus
  14. B. W. Moore, “A soluble protein characteristic of the nervous system,” Biochemical and Biophysical Research Communications, vol. 19, pp. 739–744, 1965.
  15. D. B. Zimmer, E. H. Cornwall, A. Landar, and W. Song, “The S100 protein family: history, function, and expression,” Brain Research Bulletin, vol. 37, no. 4, pp. 417–429, 1995. View at Publisher · View at Google Scholar · View at Scopus
  16. M. J. Vanstapel, K. C. Gatter, and C. De Wolf-Peeters, “New sites of human S-100 immunoreactivity detected with monoclonal antibodies,” American Journal of Clinical Pathology, vol. 85, no. 2, pp. 160–168, 1986. View at Scopus
  17. S. W. Weiss and B. J. Nickoloff, “CD 34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumours and related lesions,” American Journal of Clinical Pathology, vol. 87, p. 425, 1987.
  18. J. J. Sciubba and R. B. Brannon, “Myoepithelioma of salivary glands: report of 23 cases,” Cancer, vol. 49, no. 3, pp. 562–572, 1982. View at Scopus
  19. R. J. Zarbo, J. A. Regezi, and J. G. Batsakis, “S-100 protein in salivary gland tumors: an immunohistochemical study of 129 cases,” Head & Neck Surgery, vol. 8, no. 4, pp. 268–275, 1986. View at Scopus
  20. K. Hara, M. Ito, and J. Takeuchi, “Distribution of S-100b protein in normal salivary glands and salivary gland tumors,” Virchows Archiv A, vol. 401, no. 2, pp. 232–249, 1983. View at Scopus
  21. C. Anderson, D. Krutchkoff, C. Pedersen, R. Cartun, and M. Berman, “Polymorphous low grade adenocarcinoma of minor salivary gland: a clinicopathologic and comparative immunohistochemical study,” Modern Pathology, vol. 3, no. 1, pp. 76–82, 1990. View at Scopus
  22. C. H. Siar and K. H. Ng, “Patterns of expression of intermediate filaments and S-100 protein in desmoplastic ameloblastoma,” The Journal of Nihon University School of Dentistry, vol. 35, no. 2, pp. 104–108, 1993. View at Scopus
  23. E. Kawahara, Y. Oda, A. Ooi, S. Katsuda, I. Nakanishi, and S. Umeda, “Expression of glial fibrillary acidic protein (GFAP) in peripheral nerve sheath tumors. A comparative study of immunoreactivity of GFAP, vimentin, S-100 protein, and neurofilament in 38 Schwannomas and 18 neurofibromas,” American Journal of Surgical Pathology, vol. 12, no. 2, pp. 115–120, 1988. View at Scopus
  24. B. Seshi, L. True, D. Carter, and J. Rosai, “Immunohistochemical characterization of a set of monoclonal antibodies to human neuron-sepcific enolase,” American Journal of Pathology, vol. 131, no. 2, pp. 258–269, 1988. View at Scopus
  25. M. Mukai, C. Torikata, and H. Iri, “Expression of neurofilament triplet proteins in human neural tumors,” American Journal of Pathology, vol. 122, no. 1, pp. 28–35, 1986. View at Scopus
  26. M. Nadji and A. R. Morales, Immunoperoxidae Technique: A Practical Approach in Tumour Diagnosis, American Society of Clinical Pathlogist Press, Chicago, Ill, USA, 1986.
  27. E. Perentes and L. J. Rubinstein, “Recent applications of immunoperoxidase histochemistry in human neuro-oncology,” Archives of Pathology and Laboratory Medicine, vol. 111, no. 9, pp. 796–812, 1987. View at Scopus
  28. V. E. Gould, B. Wiedenmann, I. Lee, et al., “Synaptophysin expression in neuroendocrine neoplasms as determined by immunocytochemistry,” American Journal of Pathology, vol. 126, no. 2, pp. 243–257, 1987. View at Scopus
  29. M. Schested and K. Hou-Jenson, “Factor V111 related ANTIGEN as an endothelial cell marker in bening and malignant diseases,” Virchows Archiv, vol. 391, p. 217, 1981.
  30. B. J. Nickoloff, “The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma,” Archives of Dermatology, vol. 127, no. 4, pp. 523–529, 1991. View at Publisher · View at Google Scholar · View at Scopus
  31. S. W. Weiss and B. J. Nickoloff, “CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions,” American Journal of Surgical Pathology, vol. 17, no. 10, pp. 1039–1045, 1993. View at Scopus
  32. B. R. De Young and M. R. Wick, “CD31: an immunohistochemical marker for endothelial cell differentiation in human neoplasms,” Applied Immunohistochemistry, vol. 1, p. 97, 1993.
  33. G. S. Wood, J. H. Beckstead, R. R. Turner, et al., “Malignant Fibrohistiocytoma tumours resemble fibroblasts,” American Journal of Surgical Pathology, vol. 10, p. 323, 1986.
  34. I. Damjanov, “Antibodies to intermediate filaments and histogenesis,” Laboratory Investigation, vol. 47, no. 3, pp. 215–217, 1982. View at Scopus
  35. M. B. Wilson, W. Stanly, and D. Sens, “Infentile fibrosarcoma a misnomer,” Pediatric Pathology, vol. 10, p. 901, 1990.
  36. A. Beham, C. Schmid, S. Hodl, and C. D. M. Fletcher, “Spindle cell and pleomorphic lipoma: an immunohistochemical study and histogenetic analysis,” Journal of Pathology, vol. 158, no. 3, pp. 219–222, 1989. View at Scopus
  37. S. Persson and L. G. Kinblom, “Metastasing gastric epotheloid leomyosarcoma in young individuals with long term survival,” Cancer, vol. 70, p. 721, 1992.
  38. Y. Tatemoto, T. Tanaka, Y. Okada, and M. Mori, “Adenomatoid odontogenic tumour: co-expression of keratin and vimentin,” Virchows Archiv, vol. 413, no. 4, pp. 341–347, 1988. View at Scopus
  39. H. Takahashi, S. Fujita, and H. Okabe, “Immunohistochemical investigation in odontogenic myxoma,” Journal of Oral Pathology and Medicine, vol. 20, no. 3, pp. 114–119, 1991. View at Scopus
  40. M. Miyauchi, T. Takata, I. Ogawa et al., “Immunohistochemical observations on a possible ameloblastic fibro-odontoma,” Journal of Oral Pathology and Medicine, vol. 25, no. 2, pp. 93–96, 1996. View at Scopus
  41. P. A. Coulombe and M. B. Omary, “‘Hard’ and ‘soft’ principles defining the structure, function and regulation of keratin intermediate filaments,” Current Opinion in Cell Biology, vol. 14, no. 1, pp. 110–122, 2002.
  42. J. P. Ouhayoun, F. Gosselin, N. Forest, S. Winter, and W. W. Franke, “Cytokeratin patterns of human oral epithelia: differences in cytokeratin synthesis in gingival epithelium and the adjacent alveolar mucosa,” Differentiation, vol. 30, no. 2, pp. 123–129, 1985. View at Scopus
  43. H. Clausen, D. Moe, K. Buschard, and E. Dabelsteen, “Keratin proteins in human oral mucosa,” Journal of Oral Pathology, vol. 15, no. 1, pp. 36–42, 1986. View at Scopus
  44. K. Heikinheimo, M. Hormia, G. Stenman, I. Virtanen, and R. P. Happonen, “Patterns of expression of intermediate filaments in ameloblastoma and human fetal tooth germ,” Journal of Oral Pathology and Medicine, vol. 18, no. 5, pp. 264–273, 1989. View at Scopus
  45. C. H. Siar and K. H. Ng, “Patterns of expression of intermediate filaments and S-100 protein in desmoplastic ameloblastoma,” The Journal of Nihon University School of Dentistry, vol. 35, no. 2, pp. 104–108, 1993. View at Scopus
  46. Y. Tatemoto, Y. Okada, and M. Mori, “Squamous odontogenic tumor: immunohistochemical identification of keratins,” Oral Surgery Oral Medicine and Oral Pathology, vol. 67, no. 1, pp. 63–67, 1989. View at Scopus
  47. Y. Tatemoto, T. Tanaka, Y. Okada, and M. Mori, “Adenomatoid odontogenic tumour: co-expression of keratin and vimentin,” Virchows Archiv, vol. 413, no. 4, pp. 341–347, 1988. View at Scopus
  48. T. Takata, M. Zhao, H. Nikai, T. Uchida, and T. Wang, “Ghost cells in calcifying odontogenic cyst express enamel-related proteins,” Histochemical Journal, vol. 32, no. 4, pp. 223–229, 2000. View at Publisher · View at Google Scholar · View at Scopus